Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia
Christian Attar Files Market Manipulation Case On Behalf of Quantum Biopharma
Freedman Normand Friedland Files Market Manipulation Case On Behalf of Quantum Biopharma
Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
Shark Tank Judge Invests In All-Natural Alcohol Detox Beverage [Forbes]